Pharmaceuticals

Pharmaceutical Business Confidence Report Q4 2013

  • KAB110123
  • 43 Pages
  • November 2013
  • Pharmaceuticals
Synopsis
Pharmaceutical Business Confidence Report Q4 2013 is a new report by Kable that analyzes pharmaceutical industry executives views on the global economy, expectations on consumer confidence, supplier prices, key business concerns, and how executives future investments are set to change in Q4 2013. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance. Apart from providing access to the opinions and strategies of global pharmaceutical industry executives, it also examines their actions surrounding business priorities, threats and opportunities, and future investment areas over the next six months.
Scope
Project industry trends and industry growth expectations in the next six months, and understand business confidence to make informed business decisions.

The report drives revenues by understanding future product investment areas and key growth regions.

Readers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the growth prospects of the industry.

The report clearly forecasts the change in supplier prices of various products, which are likely to influence the industrys growth prospects over the next six months.

Identifies the major changes in consumer confidence levels in the pharmaceutical industry over the next six months.
Summary
Why was the report written?
This report is the result of an extensive survey drawn from Kables exclusive panel of leading global pharmaceutical industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the pharmaceutical industry, and forecasts company and industry growth prospects over the next six months. Furthermore, it also provides information about the impact of consumer confidence, supplier prices, and staff headcount likely to affect the investment decisions of the industry over the next six months.

What is the current market landscape and what is changing?
Overall, 66% and 50% of global pharmaceutical industry executives are optimistic about the future growth prospects of both their company and the industry over the next six months, respectively.

What are the key drivers behind recent market changes?
Optimism towards industry and company growth is driven by the improving global economic conditions, increasing in consumer spending, and the introduction of new products in the market.

What makes this report unique and essential to read?
Pharmaceutical Business Confidence Report Q4 2013 is a new report by Kable that analyzes the industry sentiments globally on the latest economic and consumer issues and their impact upon investment decisions and growth prospects within the pharmaceutical industry. This report also examines the executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermore, it analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over the next six months. In addition, it provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over the next six months.
ReasonsToBuy
According to pharmaceutical industry respondents, the present economic conditions in the Middle East and Africa are deemed to be unfavourable.

New Government proposals/legislation, performance of North American economies, and the current state of the global economy are the key concerns among global pharmaceutical industry executives.

Overall, survey respondents forecast that supplier prices for semi-finished products will increase at an average of 3%, with those from Asia-Pacific expecting the biggest rise.

The majority of global pharmaceutical industry executives anticipate no change in consumer confidence in the industry, in the next six months.

Overall, industry executives exhibit high levels of optimism towards company growth prospects compared to industry growth prospects, in the next six months
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Antihypertensives Market (Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antihypertensives are the drugs that are used to treat high blood pressure. Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Macular Edema and Macular Degeneration Market (Types, treatment and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Macular edema is a condition in which the retinal layers around the fovea is accumulated by the fluid that leads to the vision impairment and also might lead to the vision loss. Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Therapeutic Vaccines Market (Product, Technology, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020

Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Ovarian Cancer Drugs Market (Drugs and geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation

Ovarian cancer is cancer that affects the ovaries. According to the WHO, an estimated 2,38,700 women were diagnosed with ovarian cancer in 2012. The report analyzes the demand for ovarian ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Non Small-Cell Lung Cancer Market (Type, Therapy and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Non-small cell Lung cancer is the malignant tissue formation in the lung, usually in the cell lining air passage, which is characterized by abnormal cell growth in lung tissue. Globally, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Hormone Refractory Breast Cancer Asia-Pacific Market Research Report, 2013 - 2020

Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. According to the estimates of World Health Organization, cancer is the most ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>